| 2019-02-12 | Gossamer Bio, Inc. GOSS | director | 14,400 0.0343% | $16.00 | $230,400 | +6.27% | ||
| 2017-01-18 | Sale | Jazz Pharmaceuticals plc JAZZ | EVP & COO | 4,000 0.0067% | $128.75 | $515,000 | +13.46% | |
| 2016-08-09 | Sale | Jazz Pharmaceuticals plc JAZZ | EVP & COO | 4,000 0.0066% | $148.66 | $594,640 | -10.43% | |
| 2016-04-12 | Sale | Jazz Pharmaceuticals plc JAZZ | EVP & COO | 4,000 0.0065% | $136.98 | $547,920 | -4.05% | |
| 2015-08-11 | Sale | Jazz Pharmaceuticals plc JAZZ | EVP & Chief Commercial Officer | 1,000 0.0016% | $177.82 | $177,820 | -20.95% | |
| 2015-04-14 | Sale | Jazz Pharmaceuticals plc JAZZ | EVP & COO | 1,000 0.0016% | $181.45 | $181,450 | -21.27% | |
| 2015-03-05 | Sale | Jazz Pharmaceuticals plc JAZZ | EVP & COO | 1,000 0.0016% | $175.10 | $175,100 | -6.09% | |
| 2014-06-20 | Sale | Jazz Pharmaceuticals plc JAZZ | EVP & Chief Operating Officer | 4,000 0.0067% | $155.00 | $620,000 | +9.48% | |
| 2014-02-27 | Sale | Jazz Pharmaceuticals plc JAZZ | EVP & Chief Commercial Officer | 8,000 0.0135% | $164.59 | $1.32M | -5.85% | |
| 2013-09-04 | Sale | Jazz Pharmaceuticals plc JAZZ | EVP & Chief Commercial Officer | 2,000 0.0034% | $88.16 | $176,320 | +56.55% | |
| 2013-08-01 | Sale | Jazz Pharmaceuticals plc JAZZ | EVP & Chief Commercial Officer | 4,000 0.0069% | $76.22 | $304,880 | +73.56% | |
| 2013-05-20 | Sale | Jazz Pharmaceuticals plc JAZZ | EVP & Chief Commercial Officer | 2,000 0.0034% | $58.54 | $117,080 | +87.25% | |
| 2012-10-01 | Sale | Jazz Pharmaceuticals plc JAZZ | EVP & Chief Commercial Officer | 10,000 0.0173% | $57.24 | $572,400 | -0.2% | |
| 2012-03-09 | Sale | Jazz Pharmaceuticals plc JAZZ | EVP & Chief Commercial Officer | 10,000 0.0189% | $49.56 | $495,600 | +3.47% |